Hartree Partners’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102K Sell
4,000
-26,000
-87% -$612K 0.02% 105
2026
Q1
$449K Sell
30,000
-20,000
-40% -$341K 0.1% 94
2025
Q4
$728K Buy
+50,000
New +$872K 0.26% 48
2025
Q3
Sell
-36,000
Closed -$615K 85
2025
Q2
$615K Buy
+36,000
New +$360K 0.17% 41

Other funds holding CORZ

Hartree Partners's CORZ Position: Q2 2026 in Review

Hartree Partners reduced its Core Scientific (CORZ) stake by 87% in Q2 2026, selling an estimated $612K and leaving 4,000 shares worth $102K. The position accounts for 0.02% of the portfolio, ranked #105.

Hartree Partners first reported a position in CORZ in Q2 2025 and has held it in 4 quarters since. The position peaked at $728K in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Hartree Partners held 4,000 shares of Core Scientific worth $102K as of Q2 2026.
  • Hartree Partners sold 26,000 Core Scientific shares in Q2 2026, an estimated $612K.
  • Core Scientific made up 0.02% of Hartree Partners's portfolio in Q2 2026, its #105 holding.
  • Hartree Partners first reported a position in Core Scientific in Q2 2025 and has held it in 4 quarters since.
  • Hartree Partners's Core Scientific position peaked at $728K in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Hartree Partners's 13F filing for Q2 2026, filed 12 Aug 2026.